Cochrane Db Syst Rev
-
Cochrane Db Syst Rev · May 2015
Review Meta AnalysisTong-xin-luo capsule for patients with coronary heart disease after percutaneous coronary intervention.
Percutaneous coronary intervention (PCI) is a standard treatment for coronary heart disease (CHD). Restenosis, defined as a 50% reduction in luminal diameter at six months after PCI, indicates a need for revascularisation. Restenosis has proven to be a major drawback to PCI. Tong-xin-luo is one of the prophylactic strategies for cardiovascular events in patients after PCI that is widely used in China, but its efficacy and safety have not been systematically evaluated. ⋯ The addition of Tong-xin-luo to conventional Western medicine may possibly prevent restenosis and recurrence of cardiovascular events in patients with CHD after PCI. However, the data are limited by publication bias and high risk of bias for included studies. Further high-quality trials are required to evaluate the potential effects of this intervention.
-
Cochrane Db Syst Rev · May 2015
Review Meta AnalysisWITHDRAWN: Arthroplasty versus fusion in single-level cervical degenerative disc disease.
This review was withdrawn due to non‐compliance with the Cochrane Commercial Sponsorship Policy. It has been replaced by Arthroplasty versus fusion for single‐level cervical degenerative disc disease. The editorial group responsible for this previously published document have withdrawn it from publication.
-
Cochrane Db Syst Rev · May 2015
Review Meta AnalysisWITHDRAWN: Botulinum toxin for subacute/chronic neck pain.
Withdrawn due to non‐compliance with The Cochrane Collaboration’s Commercial Sponsorship Policy The editorial group responsible for this previously published document have withdrawn it from publication.
-
Cochrane Db Syst Rev · May 2015
Review Meta AnalysisNegative pressure wound therapy for treating pressure ulcers.
Pressure ulcers, also known as bedsores, decubitus ulcers and pressure injuries, are localised areas of injury to the skin or the underlying tissue, or both. Negative pressure wound therapy (NPWT) is a treatment option for pressure ulcers; a clear, current overview of the evidence is required to facilitate decision-making regarding its use. ⋯ There is currently no rigorous RCT evidence available regarding the effects of NPWT compared with alternatives for the treatment of pressure ulcers. High uncertainty remains about the potential benefits or harms, or both, of using this treatment for pressure ulcer management.
-
Cochrane Db Syst Rev · May 2015
Review Meta AnalysisWITHDRAWN: Adjusting the pH of lidocaine for reducing pain on injection.
May 2015 This review was originally published in 2010 and at that time complied with Cochrane’s Commercial Sponsorship Policy. The Commercial Sponsorship policy was updated in 2014 (http://community.cochrane.org/organisational‐policy‐manual/appendix‐5‐commercial‐sponsorship‐policy). ⋯ The non conflicted members of the original team of authors have decided not to update the review. We have therefore decided to withdraw the review and seek new authors to update it The editorial group responsible for this previously published document have withdrawn it from publication.